Relationship between vitamin D3 level and rheumatoid arthritis patients attending Rizgary Teaching Hospital in Erbil city

Relationship between vitamin D3 level and rheumatoid arthritis patients attending Rizgary Teaching Hospital in Erbil city

Background and objective: Rheumatoid arthritis (RA) is an autoimmune disease of unknown etiology. Vitamin D3 plays an important role in bone metabolism and may also have immunomodulatory effects. This study was designed to estimate the prevalence of vitamin D3 deficiency in patients with rheumatoid...

Full description

Bibliographic Details
Main Authors:	Banaz Abdulsattar Hamad, Shwan K. Media
Format:	Article
Language:	English
Published:	Hawler Medical University 2017-08-01
Series:	Zanco Journal of Medical Sciences
Subjects:	Rheumatoid arthritis Vitamin D3 DAS28 CDAI
Online Access:	http://www.zjms-hmu.org/files/articles/240717041051.pdf

Similar Items

Implication and utility of DAS-28 squeeze in rheumatoid arthritis: an Indian experience
by: H. Singh, et al.
Published: (2022-09-01)

Evaluation of the clinical efficiency of tocilizumab versus rituximab therapy in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-08-01)

Evaluation of the clinical efficiency of tocilizumab therapy, by using DAS 28, SDAI, CDAI indices and new 2011 EULAR/ACR remission criteria in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-04-01)

The Role of Galectin-3 in The Diagnosis and Evaluation of Disease Activity in Rheumatoid Arthritis
by: Shihab Mahmood Almurshedi, et al.
Published: (2023-08-01)

Fibromyalgia as a Modifying Factor of Clinical Course of Rheumatoid Arthritis
by: Perebetyuk L.
Published: (2015-09-01)

A systematic comparison of different composite measures (DAS 28, CDAI, SDAI, and Boolean approach) for determining treatment effects on low disease activity and remission in rheumatoid arthritis
by: Kirsten Janke, et al.
Published: (2022-12-01)

Clinical efficacy of the rituximab biosimilar Acellbia® 600 mg in patients with active rheumatoid arthritis in clinical practice
by: D. A. Kusevich, et al.
Published: (2019-01-01)

Real World Experience of Disease Activity in Patients With Rheumatoid Arthritis and Response to Treatment With Varios Biologic DMARDs
by: Vladimira Boyadzhieva, et al.
Published: (2018-11-01)

The role of timely rheumatoid arthritis treatment effectiveness control
by: Larisa M. Musaeva, et al.
Published: (2023-11-01)

Comprehensive evaluation of the influence of sex differences on composite disease activity indices for rheumatoid arthritis: results from a nationwide observational cohort study
by: Takahiro Nishino, et al.
Published: (2023-03-01)

EFFICACY OF ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS (results of the Russian multicenter ETALON study)
by: Anna Olegovna Pchelintseva, et al.
Published: (2014-02-01)

ASSESSMENT OF RHEUMATOID ARTHRITIS ACTIVITY DURING PREGNANCY AND POSTPARTUM
by: E. V. Matyanova, et al.
Published: (2015-04-01)

IMPACT OF TOCILIZUMAB THERAPY ON STRUCTURAL JOINT DAMAGE PROGRESSION IN RHEUMATOID ARTHRITIS
by: Anastasia Sergeevna Avdeeva, et al.
Published: (2012-10-01)

Is CDAI comparable to DAS 28 and SDAI regarding inter-observer agreement and correlation to MHAQ in Egyptian RA patients?
by: K. El-Hadidi, et al.
Published: (2020-01-01)

Patterns of Response to Different Treatment Strategies in Seropositive Rheumatoid Arthritis Patients in a Tertiary Hospital in South‐Western Saudi Arabia: A Retrospective Study
by: AlOmair M, et al.
Published: (2021-08-01)

Vitamin D Levels Among Rheumatoid Arthritis Sudanese Patients: Prevalence and Correlation to Disease Activity – A Bicentric Study
by: Mustafa Mohamed ME, et al.
Published: (2023-09-01)

The Role of Interleukin-22 in The Diagnosis and Evaluation of Disease Activity in Rheumatoid Arthritis
by: Shihab Almurshedi, et al.
Published: (2023-06-01)

Impact of tocilizumab therapy on immunological parameters in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-06-01)

Characteristics of Anemia in Rheumatoid Arthritis
by: Anca BOBIRCA, et al.
Published: (2022-09-01)

Real-World Sarilumab Use and Rule Testing to Predict Treatment Response in Patients with Rheumatoid Arthritis: Findings from the RISE Registry
by: Jeffrey R. Curtis, et al.
Published: (2023-06-01)

DAS28 score vs. ultrasound examination for assessment of rheumatoid arthritis disease activity: comparison and discussion of pros and cons
by: Tacjana Anna Barczyńska, et al.
Published: (2015-09-01)

Do Interventions with Diet or Dietary Supplements Reduce the Disease Activity Score in Rheumatoid Arthritis? A Systematic Review of Randomized Controlled Trials
by: Josefine Nelson, et al.
Published: (2020-09-01)

The effect of polypharmacy on rheumatoid and psoriatic arthritis treatment: retrospective study
by: Mete Kara, et al.
Published: (2023-11-01)

The Use of Tocilizumab in Combination with Methotrexate in Indonesian Rheumatoid Arthritis Patients (PICTURE INA Study)
by: Bambang Setyohadi, et al.
Published: (2018-06-01)

Relationship of the clinical efficiency of tocilizumab therapy to the serum level of matrix metalloproteinase-3 in patients with rheumatoid arthritis
by: A S Avdeeva, et al.
Published: (2013-05-01)

SERUM FETUIN-A LEVELS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: E. V. Papichev, et al.
Published: (2019-09-01)

The Association of Anti-CCP and Disease Activity in Rheumatoid Arthritis
by: Raouf Rahim Merza, et al.
Published: (2014-08-01)

Serum Calprotectin in Rheumatoid Arthritis: A Promising Diagnostic Marker, How Far Is It Related to Activity and Sonographic Findings?
by: H.E. Mansour, et al.
Published: (2017-03-01)

Effects of Melatonin on Sleep Quality and Disease Activity in Patients With Rheumatoid Arthritis
by: Tayebeh Palimi, et al.
Published: (2022-06-01)

Vitamin D status in women with rheumatoid arthritis: frequency of hypovitaminosis, associations with disease activity, body composition and comorbidity
by: Olga V. Dobrovolskaya, et al.
Published: (2021-05-01)

MTHFR and MTRR Genetic Polymorphism of Methotrexate Therapy Outcomes in Early Rheumatoid Arthritis
by: Zhang Q, et al.
Published: (2023-05-01)

Vitamin D in rheumatoid arthritis and association of disease activity with various laboratory parameters
by: Ravi Kumar, et al.
Published: (2019-01-01)

Study of serum calprotectin level in rheumatoid arthritis: unexpected low level and possible explanations
by: Sarah Sayed El-Tawab, et al.
Published: (2024-01-01)

Impact of Primary Hypothyroidism on Rheumatoid Arthritis Patients
by: Marwa Abduwahab Muhammed ,, et al.
Published: (2022-12-01)

Diagnosis delay in Egyptian rheumatoid-arthritis-patients: underlying factors and outcomes — retrospective observational study
by: Sarah A. Sakr, et al.
Published: (2023-06-01)

Experience with tocilizumab in patients with rheumatoid arthritis (according to the data of the LORNET multicenter trial)
by: E Yu Panasyuk, et al.
Published: (2013-04-01)

Migraine in patients with rheumatoid arthritis and its relation to disease activity
by: Hassan Abd-Elaty El-Sonbaty, et al.
Published: (2021-11-01)

Assessment of Vitamin D3 level in patients of rheumatoid arthritis and its relationship with disease activity using DAS 28-CRP in tertiary care center of Bihar, India
by: Poonam Sinha, et al.
Published: (2022-12-01)

Frequency of Thyroid Disorders in Rheumatoid Arthritis Patients and its Association with Disease Activity: A Hospital Based Study
by: Safina Hameed Qureshi, et al.
Published: (2023-06-01)

LEVELS OF ANGIOGENESIS-REGULATORY CHEMOKINES IN THE SYNOVIAL FLUID OF PATIENTS WITH RHEUMATOID ARTHRITIS
by: D. A. Zhebrun, et al.
Published: (2015-03-01)